CN Patent

CN1829514A — Cci－779冻干制剂

Assigned to Wyeth LLC · Expires 2006-09-06 · 20y expired

What this patent protects

本申请公开了CCI－779冻干制剂和用于制备冷冻干燥的CCI－779制剂的溶液，所述溶液由CCI－779和选自二甲亚砜、乙腈、乙醇、异丙醇或叔丁醇的溶剂组成。还提供了制备CCI－779冻干制剂的方法，重新配制所述制剂的方法以及所述制剂的应用。

USPTO Abstract

本申请公开了CCI－779冻干制剂和用于制备冷冻干燥的CCI－779制剂的溶液，所述溶液由CCI－779和选自二甲亚砜、乙腈、乙醇、异丙醇或叔丁醇的溶剂组成。还提供了制备CCI－779冻干制剂的方法，重新配制所述制剂的方法以及所述制剂的应用。

Drugs covered by this patent

Torisel (temsirolimus) · Pfizer

Patent Metadata

Patent number: CN1829514A
Jurisdiction: CN
Classification: —
Expires: 2006-09-06
Drug substance claim: No
Drug product claim: No
Assignee: Wyeth LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.